San Diego, CA, United States of America

Erik J Sorensen

USPTO Granted Patents = 21 


Average Co-Inventor Count = 7.9

ph-index = 10

Forward Citations = 331(Granted Patents)


Location History:

  • La Jolla, CA (US) (1993 - 1996)
  • San Diego, CA (US) (2001 - 2010)
  • Princeton, NJ (US) (2010 - 2013)

Company Filing History:


Years Active: 1993-2013

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: **Erik J. Sorensen: Innovator in Cancer Treatment**

Introduction

Erik J. Sorensen, based in San Diego, California, is a prominent inventor known for his significant contributions to cancer research and drug development. With a remarkable portfolio of 21 patents, Sorensen is recognized for his pioneering work in the field of epothilones, a class of drugs with potential use in treating cancer.

Latest Patents

Among his latest inventions, Sorensen has developed processes for the synthesis of epothilone A and B, as well as desoxyepothilones A and B, along with various analogues. His patents provide convergent processes that enable the preparation of these compounds and their intermediates, which are essential for creating effective cancer treatments. Notably, these compositions are designed for treating cancer that has developed a multidrug-resistant phenotype, showcasing his commitment to addressing complex medical challenges.

Career Highlights

Throughout his career, Sorensen has been associated with leading research institutions such as Sloan Kettering Institute for Cancer Research and The Scripps Research Institute. His work has significantly advanced the understanding of epothilones and their potential applications in oncology.

Collaborations

Erik J. Sorensen has collaborated with notable colleagues in the field, including Samuel J. Danishefsky and Peter Bertinato. These collaborations have helped foster innovation and furthered research in cancer therapeutics, enhancing the potential impact of their collective work.

Conclusion

Erik J. Sorensen stands out as a critical figure in the ongoing battle against cancer. With his innovative approaches and extensive patent portfolio, he continues to pave the way for advancements in cancer treatment, embodying the spirit of invention and dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…